Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
Actual shortage: | 8 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-05-23 | 2018-06-22 | 50095 |
UROMITEXAN | 100MG | SOLUTION | Resolved | 2018-06-01 | 2018-06-22 | 51103 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-08-13 | 2018-08-29 | 58038 |
GENTAMICIN(E) | 1.6MG | SOLUTION | Resolved | 2018-08-20 | 2018-09-05 | 58562 |
CYSTOSOL W 3% HEXITOLS | 2.5G 500MG | LIQUID | Resolved | 2018-09-19 | 2018-10-06 | 61923 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56909 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56912 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56915 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56918 |
POTASSIUM CHLORIDE INJECTION | 29.8MG | LIQUID | Resolved | 2018-10-02 | 2018-10-18 | 62874 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26121 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32177 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26118 |
5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32181 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2019-01-14 | 2019-02-05 | 72133 |
POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-01-25 | 2019-02-05 | 73584 |
METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-01-02 | 2019-02-09 | 70778 |
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 5G 150MG 450MG | SOLUTION | Resolved | 2019-02-08 | 2019-02-13 | 75200 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-12-05 | 2019-02-26 | 68703 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-04-20 | 118601 |
CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
CLINIMIX | 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-12-08 | 118612 |
1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |